Protein misfolding and human disease.

Protein misfolding is a common event in living cells. In young and healthy cells, the misfolded protein load is disposed of by protein quality control (PQC) systems. In aging cells and in cells from certain individuals with genetic diseases, the load may overwhelm the PQC capacity, resulting in accumulation of misfolded proteins. Dependent on the properties of the protein and the efficiency of the PQC systems, the accumulated protein may be degraded or assembled into toxic oligomers and aggregates. To illustrate this concept, we discuss a number of very different protein misfolding diseases including phenylketonuria, Parkinson's disease, alpha-1-antitrypsin deficiency, familial neurohypophyseal diabetes insipidus, and short-chain acyl-CoA dehydrogenase deficiency. Despite the differences, an emerging paradigm suggests that the cellular effects of protein misfolding provide a common framework that may contribute to the elucidation of the cell pathology and guide intervention and treatment strategies of many genetic and age-dependent diseases.

[1]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[2]  M. Masucci,et al.  Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. , 2005, Human molecular genetics.

[3]  M. Bucciantini,et al.  Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates , 2005, Journal of Cell Science.

[4]  D. Perlmutter,et al.  Grp78, Grp94, and Grp170 interact with alpha1-antitrypsin mutants that are retained in the endoplasmic reticulum. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[5]  A. Goldberg,et al.  Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.

[6]  L. Serrano,et al.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002, Journal of molecular biology.

[7]  R. Ellis.  The molecular chaperone concept. , 1990, Seminars in cell biology.

[8]  David Murphy,et al.  Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  S. Packman,et al.  The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? , 1997, Human molecular genetics.

[10]  L. Bruijn,et al.  Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.

[11]  F. Bricaire,et al.  Neurodegenerative diseases and oxidative stress. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Nicholas J. Hoogenraad,et al.  Molecular Chaperones Hsp90 and Hsp70 Deliver Preproteins to the Mitochondrial Import Receptor Tom70 , 2003, Cell.

[13]  P. Bross,et al.  Biochemical characterization of purified, human recombinant Lys304-->Glu medium-chain acyl-CoA dehydrogenase containing the common disease-causing mutation and comparison with the normal enzyme. , 1997, European journal of biochemistry.

[14]  Ellis Rj.  The molecular chaperone concept. , 1990 .

[15]  R. Ellis,et al.  Macromolecular crowding: an important but neglected aspect of the intracellular environment. , 2001, Current opinion in structural biology.

[16]  M. Duchen,et al.  Mitochondria, Ca2+ and neurodegenerative disease. , 2002, European journal of pharmacology.

[17]  L. Bolund,et al.  Misfolding, Degradation, and Aggregation of Variant Proteins , 2003, Journal of Biological Chemistry.

[18]  P. Muchowski,et al.  Modulation of neurodegeneration by molecular chaperones , 2005, Nature Reviews Neuroscience.

[19]  T. Rapoport,et al.  Retro-translocation of proteins from the endoplasmic reticulum into the cytosol , 2002, Nature Reviews Molecular Cell Biology.

[20]  Milan Macek,et al.  Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening , 2002, Human mutation.

[21]  D. Perlmutter.  α1-Antitrypsin Deficiency , 2011 .

[22]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[23]  F. Hartl,et al.  An unstable transmembrane segment in the cystic fibrosis transmembrane conductance regulator , 1999, The EMBO journal.

[24]  G. Petsko,et al.  Misfolded Proteins Are Competent to Mediate a Subset of the Responses to Heat Shock in Saccharomyces cerevisiae * 210 , 2002, The Journal of Biological Chemistry.

[25]  D. Perlmutter,et al.  Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. , 2005, The Journal of biological chemistry.

[26]  M. Prevost,et al.  A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.

[27]  V. Yee,et al.  Characterization of Four Variant Forms of Human Propionyl-CoA Carboxylase Expressed in Escherichia coli* , 2005, Journal of Biological Chemistry.

[28]  J. Wakefield,et al.  Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines* , 2004, Journal of Biological Chemistry.

[29]  N. Gregersen,et al.  Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis , 2004, European Journal of Human Genetics.

[30]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[31]  J. Frydman.  Folding of newly translated proteins in vivo: the role of molecular chaperones. , 2001, Annual review of biochemistry.

[32]  N. Pfanner,et al.  The Protein Import Machinery of Mitochondria* , 2004, Journal of Biological Chemistry.

[33]  J. Saffitz,et al.  Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Fabrizio Chiti,et al.  Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity* , 2004, Journal of Biological Chemistry.

[35]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[36]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[37]  Patricia L Clark,et al.  Protein folding in the cell: reshaping the folding funnel. , 2004, Trends in biochemical sciences.

[38]  Modesto Orozco,et al.  PMUT: a web-based tool for the annotation of pathological mutations on proteins , 2005, Bioinform..

[39]  P. Csermely,et al.  Aging and molecular chaperones , 2003, Experimental Gerontology.

[40]  C. Richter-Landsberg,et al.  Stress proteins in neural cells: functional roles in health and disease , 2003, Cellular and Molecular Life Sciences CMLS.

[41]  J. Kelly,et al.  The Biological and Chemical Basis for Tissue-Selective Amyloid Disease , 2005, Cell.

[42]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[43]  A. Dürr,et al.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. , 2002, American journal of human genetics.

[44]  D. Perlmutter,et al.  Accumulation of Mutant α1-Antitrypsin Z in the Endoplasmic Reticulum Activates Caspases-4 and -12, NFκB, and BAP31 but Not the Unfolded Protein Response* , 2005, Journal of Biological Chemistry.

[45]  M. Amaral,et al.  Most F508del-CFTR Is Targeted to Degradation at an Early Folding Checkpoint and Independently of Calnexin , 2005, Molecular and Cellular Biology.

[46]  C. Jacob,et al.  Oxidative activation of antioxidant defence. , 2005, Trends in biochemical sciences.

[47]  M. Groll,et al.  Molecular shredders: how proteasomes fulfill their role. , 2003, Current opinion in structural biology.

[48]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[49]  M. Ryan,et al.  A mitochondrial specific stress response in mammalian cells , 2002, The EMBO journal.

[50]  K. Uchida,et al.  4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. , 2003, Progress in lipid research.

[51]  A. Ballabio,et al.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia , 2003, The Journal of cell biology.

[52]  Beate Gerstbrein,et al.  Dying for a cause: invertebrate genetics takes on human neurodegeneration , 2003, Nature Reviews Genetics.

[53]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[54]  M. Spiess,et al.  Degradation of Wild-type Vasopressin Precursor and Pathogenic Mutants by the Proteasome* , 2004, Journal of Biological Chemistry.

[55]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[56]  M. Ugarte,et al.  Expression Analysis of Phenylketonuria Mutations , 2000, The Journal of Biological Chemistry.

[57]  M. Maurizi,et al.  AAA proteins: in search of a common molecular basis , 2001, EMBO reports.

[58]  Daniel Kaganovich,et al.  Protein quality control: chaperones culling corrupt conformations , 2005, Nature Cell Biology.

[59]  J. Riordan,et al.  The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon. , 2004, Gastroenterology.

[60]  R. Schekman,et al.  Bi-directional protein transport between the ER and Golgi. , 2004, Annual review of cell and developmental biology.

[61]  I. Batinic-Haberle,et al.  Oxidants, antioxidants and the ischemic brain , 2004, Journal of Experimental Biology.

[62]  K. Dill.  Theory for the folding and stability of globular proteins. , 1985, Biochemistry.

[63]  Daniel J Klionsky,et al.  Development by self-digestion: molecular mechanisms and biological functions of autophagy. , 2004, Developmental cell.

[64]  E. Schon,et al.  Neuronal degeneration and mitochondrial dysfunction. , 2003, The Journal of clinical investigation.

[65]  R. Frizzell,et al.  The role of regulated CFTR trafficking in epithelial secretion. , 2003, American journal of physiology. Cell physiology.

[66]  H. Horvitz,et al.  Superoxide Dismutase Concentration and Activity in Familial Amyotrophic Lateral Sclerosis , 1995, Journal of neurochemistry.

[67]  J. Frydman,et al.  Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation , 2005, The FEBS journal.

[68]  T. Sommer,et al.  ERAD: the long road to destruction , 2005, Nature Cell Biology.

[69]  J. Vasiliev,et al.  Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis , 2004, Molecular and Cellular Biochemistry.

[70]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[71]  J. Christensen,et al.  Autosomal dominant familial neurohypophyseal diabetes insipidus. , 2003, APMIS. Supplementum.

[72]  Steven W. Taylor,et al.  Global organellar proteomics. , 2003, Trends in biotechnology.

[73]  D. Perlmutter.  Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. , 2002, The Journal of clinical investigation.

[74]  L. Bolund,et al.  Expression of three different mutations in the arginine vasopressin gene suggests genotype–phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds , 2005, Clinical endocrinology.

[75]  Valerie Daggett,et al.  The complete folding pathway of a protein from nanoseconds to microseconds , 2003, Nature.

[76]  A. Fersht,et al.  Protein Folding and Unfolding at Atomic Resolution , 2002, Cell.

[77]  R. Kopito,et al.  Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.

[78]  C. Isidoro,et al.  Autophagy‐dependent cell survival and cell death in an autosomal dominant familial neurohypophyseal diabetes insipidus in vitro model , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[80]  J. Teckman,et al.  Mitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency , 2004 .

[81]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[82]  C. Levinthal.  Are there pathways for protein folding , 1968 .

[83]  Mark C. Field,et al.  ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome. , 2005, Human molecular genetics.

[84]  P. Stenson,et al.  Human Gene Mutation Database (HGMD , 2003 .

[85]  D. J. Naylor,et al.  Proteome-wide Analysis of Chaperonin-Dependent Protein Folding in Escherichia coli , 2005, Cell.

[86]  Andrew B West,et al.  Molecular pathophysiology of Parkinson's disease. , 2005, Annual review of neuroscience.

[87]  F. Hartl,et al.  Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.

[88]  M. Stefani.  Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. , 2004, Biochimica et biophysica acta.

[89]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[90]  D. Rudnick,et al.  CONCISE REVIEW IN MECHANISMS OF DISEASE Alpha-1-Antitrypsin Deficiency: A New Paradigm for Hepatocellular Carcinoma in Genetic Liver Disease , 2005 .

[91]  J. Jameson,et al.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. , 2003, Journal of Clinical Investigation.

[92]  K. Tanaka,et al.  Intramitochondrial folding and assembly of medium-chain acyl-CoA dehydrogenase (MCAD). Demonstration of impaired transfer of K304E-variant MCAD from its complex with hsp60 to the native tetramer. , 1994, Journal of Biological Chemistry.

[93]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[94]  L. Bolund,et al.  Effects of Two Mutations Detected in Medium Chain Acyl-CoA Dehydrogenase (MCAD)-deficient Patients on Folding, Oligomer Assembly, and Stability of MCAD Enzyme (*) , 1995, The Journal of Biological Chemistry.

[95]  P. Waters.  How PAH gene mutations cause hyper‐phenylalaninemia and why mechanism matters: Insights from in vitro expression , 2003, Human mutation.

[96]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[97]  K. Davies,et al.  Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. , 2004, The international journal of biochemistry & cell biology.

[98]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[99]  R. Kopito,et al.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. , 1994, The Journal of biological chemistry.

[100]  Peter Bross,et al.  Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships. , 2004, European journal of biochemistry.

[101]  Judith Frydman,et al.  Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. , 2004, Trends in cell biology.

[102]  A. Tamura,et al.  Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[103]  T. Langer,et al.  Protein degradation in mitochondria. , 2000, Seminars in cell & developmental biology.

[104]  L. Bolund,et al.  Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. , 2004, The Journal of clinical endocrinology and metabolism.

[105]  R. Dean,et al.  Recent developments in the intracellular degradation of oxidized proteins. , 2002, Free radical biology & medicine.

[106]  S. Henikoff,et al.  Predicting the effects of amino acid substitutions on protein function. , 2006, Annual review of genomics and human genetics.

[107]  D. Lomas,et al.  α1-Antitrypsin deficiency • 4: Molecular pathophysiology , 2004, Thorax.

[108]  C. Anfinsen.  Principles that govern the folding of protein chains. , 1973, Science.